novo nordisk oral semaglutide fda approval With of Wegovy pill, new era of GLP-1 weight loss drugs begins Novo Nordisk wins US approval

Wegovy and atrial fibrillation specifically A 2025 analysis of the SELECT trial, presented at the European Society of Cardiology Congress, looked specifically at AF

Larsen, Anna T

Instead, we need to approach them with a more comprehensive understanding of their effects on gut health

This pulls the subcutaneous fat away from the underlying muscle, ensuring the medication goes exactly where it is intended

It is approved for those 7 years old and older, but is not recommended for people with breathing problems such asthma or COPD

The metabolic shift produces measurable changes in insulin sensitivity, inflammatory markers, triglyceride levels, and appetite-regulating hormones